# BIONEXUS GENE LAB CORP COM

BIONEXUS GENE LAB CORP COM is a security (CUSIP 090628306) tracked across SEC portfolio filings. 4 institutional managers reported $499 on Form 13F as of 2026-06-30; 1 registered fund positions totaling $6 via N-PORT as of 2026-03-31.

## Summary

- Issuer: BIONEXUS GENE LAB CORP
- Class: COM
- CUSIP: 090628306
- Asset category: EC
- 13F holders: 4
- 13F value: $499
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $6
- N-PORT report: 2026-03-31

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| UBS Group AG | Zurich, V8 | $495 | 231 |
| Caitong International Asset Management Co., Ltd | HONG KONG, K3 | $2 | 1 |
| WELLS FARGO & COMPANY/MN | SAN FRANCISCO, CA | $2 | 1 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [Blackstone Alternative Multi-Strategy Fund](https://search.stillhousedata.com/fund/S000045538) | Blackstone Alternative Investment Funds | $6 | 0.00% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/090628306.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.